CRVO logo

CervoMed (CRVO) EBITDA

Annual EBITDA

-$2.17 M
+$3.63 M+62.57%

December 31, 2023

Summary

Performance

1-Year Change

+62.57%

3-Year Change

+86.32%

5-Year Change

+81.78%

15-Year Change

+80.75%

CRVO EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

76.35%
CRVO annual EBITDA is higher than 76.35% of companies in Healthcare sector

High & Low

All-time High

$813.00 K
CRVO annual EBITDA is currently -367.15% below its historical high of $813.00 thousand

3-Year Low

-$15.94 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
CRVO previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Apr 1, 2025
CRVO next annual earnings announcement is scheduled for Apr 1, 2025

OtherCRVOprofitabilitymetrics:

Annual Revenue

-
CRVO annual revenue value is unknown

Annual Net Income

-$2.17 M
CRVO annual net profit is -$2.17 million

Annual EBIT

-$2.17 M
CRVO annual earnings before interest & taxes is -$2.17 million

Annual EPS

-$0.82
CRVO annual earnings per share is -$0.82

Quarterly EBITDA

-$5.40 M
-$2.40 M-80.17%

September 30, 2024

Summary

Performance

3-Month Change

-80.17%

1-Year Change

-107.96%

3-Year Change

-107.96%

5-Year Change

-107.96%

CRVO Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

46.1%
CRVO quarterly EBITDA is higher than 46.1% of companies in Healthcare sector

High & Low

All-time High

$16.15 M
CRVO quarterly EBITDA is currently -133.42% below its historical high of $16.15 million

3-Year Low

-$5.40 M
CRVO quarterly EBITDA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CRVO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Apr 1, 2025
CRVO next earnings announcement is scheduled for Apr 1, 2025

OtherCRVOprofitabilitymetrics:

Quarterly Revenue

-
CRVO quarterly revenue value is unknown

Quarterly Net Income

-$4.75 M
CRVO quarterly net profit is -$4.75 million

Quarterly EBIT

-$5.40 M
CRVO quarterly earnings before interest & taxes is -$5.40 million

Quarterly EPS

-$0.55
CRVO quarterly earnings per share is -$0.55

TTM EBITDA

-$7.83 M
-$2.72 M-53.31%

September 30, 2024

Summary

Performance

3-Month Change

-53.31%

1-Year Change

-134.27%

3-Year Change

-134.27%

5-Year Change

-134.27%

CRVO TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

65.42%
CRVO TTM EBITDA is higher than 65.42% of companies in Healthcare sector

High & Low

All-time High

$15.09 M
CRVO TTM EBITDA is currently -151.87% below its historical high of $15.09 million

3-Year Low

-$16.28 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CRVO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Apr 1, 2025
CRVO next earnings announcement is scheduled for Apr 1, 2025

OtherCRVOprofitabilitymetrics:

TTM Revenue

-
CRVO TTM revenue value is unknown

TTM Net Income

-$11.95 M
CRVO TTM net profit is -$11.95 million

TTM EBIT

-$7.83 M
CRVO TTM earnings before interest & taxes is -$7.83 million

TTM EPS

-$1.65
CRVO TTM earnings per share is -$1.65

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$2.17 M
CRVO annual EBITDA is -$2.17 million

Annual Net Income

-$2.17 M
CRVO annual net profit is -$2.17 million

Annual Interest Expense

$0.00
CRVO annual interest expense is $0.00

Annual Income Tax

-
CRVO annual income tax value is unknown

Annual D&A

-
CRVO annual depreciation & amortization value is unknown

CRVO EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+62.6%-108.0%-134.3%
3 y3 years+86.3%-108.0%-134.3%
5 y5 years+81.8%-108.0%-134.3%

CRVO EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+86.4%-270.7%at low-260.3%+51.9%
5 y5-yearat high+86.4%-270.7%at low-260.3%+56.0%
alltimeall time-367.1%+90.3%-133.4%+74.4%-151.9%+80.5%

CervoMed EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$5.40 M(+80.2%)
-$7.83 M(+53.3%)
Jun 2024
-
-$3.00 M(+15.4%)
-$5.10 M(+52.8%)
Mar 2024
-
-$2.59 M(-182.1%)
-$3.34 M(+53.8%)
Dec 2023
-$2.17 M(-62.6%)
$3.16 M(-218.1%)
-$2.17 M(-74.7%)
Sep 2023
-
-$2.68 M(+117.3%)
-$8.60 M(+25.9%)
Jun 2023
-
-$1.23 M(-13.7%)
-$6.83 M(-30.6%)
Mar 2023
-
-$1.43 M(-56.3%)
-$9.84 M(-24.1%)
Dec 2022
-$5.80 M(-63.6%)
-
-
Dec 2022
-
-$3.27 M(+261.2%)
-$12.97 M(-1.3%)
Sep 2022
-
-$904.10 K(-78.7%)
-$13.14 M(-19.2%)
Jun 2022
-
-$4.25 M(-6.8%)
-$16.28 M(+2.8%)
Mar 2022
-
-$4.55 M(+32.4%)
-$15.84 M(-0.7%)
Dec 2021
-$15.94 M(+0.5%)
-$3.44 M(-14.8%)
-$15.94 M(-3.8%)
Sep 2021
-
-$4.04 M(+5.9%)
-$16.57 M(-6.8%)
Jun 2021
-
-$3.81 M(-18.3%)
-$17.78 M(+1.0%)
Mar 2021
-
-$4.66 M(+14.7%)
-$17.60 M(+10.9%)
Dec 2020
-$15.87 M(+38.6%)
-$4.06 M(-22.6%)
-$15.87 M(+7.7%)
Sep 2020
-
-$5.25 M(+44.6%)
-$14.74 M(+17.7%)
Jun 2020
-
-$3.63 M(+24.0%)
-$12.53 M(+9.1%)
Mar 2020
-
-$2.93 M(-0.1%)
-$11.48 M(+0.2%)
Dec 2019
-$11.45 M(-3.9%)
-$2.93 M(-3.3%)
-$11.45 M(+1.3%)
Sep 2019
-
-$3.03 M(+17.3%)
-$11.31 M(+2.5%)
Jun 2019
-
-$2.59 M(-10.8%)
-$11.03 M(-4.0%)
Mar 2019
-
-$2.90 M(+4.2%)
-$11.50 M(-3.5%)
Dec 2018
-$11.92 M(+5.7%)
-$2.78 M(+0.9%)
-$11.92 M(+3.1%)
Sep 2018
-
-$2.76 M(-9.6%)
-$11.56 M(-4.6%)
Jun 2018
-
-$3.05 M(-8.2%)
-$12.12 M(+0.6%)
Mar 2018
-
-$3.32 M(+37.0%)
-$12.04 M(+6.8%)
Dec 2017
-$11.28 M(-38.5%)
-$2.43 M(-26.9%)
-$11.28 M(-1.0%)
Sep 2017
-
-$3.32 M(+11.5%)
-$11.39 M(-17.9%)
Jun 2017
-
-$2.98 M(+16.2%)
-$13.87 M(-5.6%)
Mar 2017
-
-$2.56 M(+1.0%)
-$14.69 M(-19.9%)
Dec 2016
-$18.35 M(+186.8%)
-$2.54 M(-56.2%)
-$18.34 M(-0.2%)
Sep 2016
-
-$5.79 M(+52.7%)
-$18.37 M(+32.0%)
Jun 2016
-
-$3.79 M(-39.0%)
-$13.92 M(+21.9%)
Mar 2016
-
-$6.22 M(+142.1%)
-$11.42 M(+78.5%)
Dec 2015
-$6.40 M(-60.8%)
-$2.57 M(+91.0%)
-$6.40 M(-45.1%)
Sep 2015
-
-$1.34 M(+3.7%)
-$11.66 M(-13.3%)
Jun 2015
-
-$1.30 M(+8.8%)
-$13.45 M(-17.7%)
Mar 2015
-
-$1.19 M(-84.8%)
-$16.34 M(+0.4%)
Dec 2014
-$16.33 M
-$7.83 M(+149.3%)
-$16.28 M(+66.6%)
Sep 2014
-
-$3.14 M(-24.9%)
-$9.77 M(+18.6%)
Jun 2014
-
-$4.18 M(+269.8%)
-$8.24 M(+436.5%)
DateAnnualQuarterlyTTM
Mar 2014
-
-$1.13 M(-14.2%)
-$1.54 M(-43.6%)
Dec 2013
-$2.72 M(-58.2%)
-$1.32 M(-18.0%)
-$2.72 M(-118.5%)
Sep 2013
-
-$1.61 M(-163.8%)
$14.74 M(-2.3%)
Jun 2013
-
$2.52 M(-208.7%)
$15.09 M(-276.6%)
Mar 2013
-
-$2.32 M(-114.4%)
-$8.54 M(+31.0%)
Dec 2012
-$6.52 M(-71.0%)
$16.15 M(-1381.6%)
-$6.52 M(-82.5%)
Sep 2012
-
-$1.26 M(-94.0%)
-$37.33 M(-7.1%)
Jun 2012
-
-$21.11 M(+7058.0%)
-$40.19 M(+90.3%)
Mar 2012
-
-$294.90 K(-98.0%)
-$21.12 M(-6.1%)
Dec 2011
-$22.49 M(+171.6%)
-$14.66 M(+256.0%)
-$22.49 M(+95.9%)
Sep 2011
-
-$4.12 M(+101.6%)
-$11.48 M(+27.7%)
Jun 2011
-
-$2.04 M(+23.0%)
-$8.99 M(+2.7%)
Mar 2011
-
-$1.66 M(-54.6%)
-$8.76 M(+5.8%)
Dec 2010
-$8.28 M(+156.2%)
-$3.66 M(+124.2%)
-$8.28 M(+33.3%)
Sep 2010
-
-$1.63 M(-9.8%)
-$6.21 M(+20.9%)
Jun 2010
-
-$1.81 M(+52.7%)
-$5.14 M(+37.3%)
Mar 2010
-
-$1.18 M(-25.4%)
-$3.74 M(+27.9%)
Dec 2009
-$3.23 M(+180.6%)
-$1.59 M(+185.4%)
-$2.93 M(+67.1%)
Sep 2009
-
-$556.00 K(+34.3%)
-$1.75 M(+19.2%)
Jun 2009
-
-$414.00 K(+12.1%)
-$1.47 M(+15.3%)
Mar 2009
-
-$369.20 K(-10.3%)
-$1.27 M(+10.6%)
Dec 2008
-$1.15 M(+1963.6%)
-$411.50 K(+49.9%)
-$1.15 M(-1664.5%)
Sep 2008
-
-$274.50 K(+25.5%)
$73.60 K(-65.4%)
Jun 2008
-
-$218.80 K(-11.3%)
$212.80 K(+79.3%)
Mar 2008
-
-$246.70 K(-130.3%)
$118.70 K(-1073.0%)
Dec 2007
-$55.80 K(+33.2%)
$813.60 K(-701.3%)
-$12.20 K(-98.6%)
Sep 2007
-
-$135.30 K(-56.8%)
-$856.90 K(+18.2%)
Jun 2007
-
-$312.90 K(-17.1%)
-$725.20 K(+58.7%)
Mar 2007
-
-$377.60 K(+1114.1%)
-$457.00 K(+450.6%)
Dec 2006
-$41.90 K(-54.6%)
-$31.10 K(+763.9%)
-$83.00 K(+59.9%)
Sep 2006
-
-$3600.00(-91.9%)
-$51.90 K(+7.5%)
Jun 2006
-
-$44.70 K(+1141.7%)
-$48.30 K(+1241.7%)
Mar 2006
-
-$3600.00(-99.9%)
-$3600.00(-100.0%)
Dec 2005
-$92.20 K(-98.7%)
-
-
Sep 2000
-
-$4.12 M(+281.0%)
-$11.56 M(+33.9%)
Jun 2000
-
-$1.08 M(-3.2%)
-$8.64 M(+6.6%)
Mar 2000
-
-$1.12 M(-78.6%)
-$8.10 M(+19.4%)
Dec 1999
-$6.84 M(-941.0%)
-$5.24 M(+336.4%)
-$6.79 M(+314.8%)
Sep 1999
-
-$1.20 M(+118.7%)
-$1.64 M(+4481.8%)
Jun 1999
-
-$548.70 K(-374.4%)
-$35.70 K(-107.0%)
Mar 1999
-
$200.00 K(-329.9%)
$513.00 K(+63.9%)
Dec 1998
$813.00 K
-$87.00 K(-121.8%)
$313.00 K(-21.8%)
Sep 1998
-
$400.00 K
$400.00 K

FAQ

  • What is CervoMed annual EBITDA?
  • What is the all time high annual EBITDA for CervoMed?
  • What is CervoMed annual EBITDA year-on-year change?
  • What is CervoMed quarterly EBITDA?
  • What is the all time high quarterly EBITDA for CervoMed?
  • What is CervoMed quarterly EBITDA year-on-year change?
  • What is CervoMed TTM EBITDA?
  • What is the all time high TTM EBITDA for CervoMed?
  • What is CervoMed TTM EBITDA year-on-year change?

What is CervoMed annual EBITDA?

The current annual EBITDA of CRVO is -$2.17 M

What is the all time high annual EBITDA for CervoMed?

CervoMed all-time high annual EBITDA is $813.00 K

What is CervoMed annual EBITDA year-on-year change?

Over the past year, CRVO annual EBITDA has changed by +$3.63 M (+62.57%)

What is CervoMed quarterly EBITDA?

The current quarterly EBITDA of CRVO is -$5.40 M

What is the all time high quarterly EBITDA for CervoMed?

CervoMed all-time high quarterly EBITDA is $16.15 M

What is CervoMed quarterly EBITDA year-on-year change?

Over the past year, CRVO quarterly EBITDA has changed by -$2.80 M (-107.96%)

What is CervoMed TTM EBITDA?

The current TTM EBITDA of CRVO is -$7.83 M

What is the all time high TTM EBITDA for CervoMed?

CervoMed all-time high TTM EBITDA is $15.09 M

What is CervoMed TTM EBITDA year-on-year change?

Over the past year, CRVO TTM EBITDA has changed by -$4.49 M (-134.27%)